Drug combination screen identifies pemigatinib, an FGFR inhibitor, as a mechanism to overcome KRASG12C inhibitor resistance in lung cancerAngela Abdollahi,Margaret Favata,Darlise DiMatteo, Sean Schuette, Erika Boarder,Mark Rupar,Ricardo Macarron, Aidan Gilmartin, Hui Wang,Alejandro Amador-ArjonaCANCER RESEARCH(2023)引用 0|浏览34暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要